Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease.

Shorter, Edward; Tyrer, Peter · BMJ · 2003

review · Level V

Where this comes from

Abstract

No new drugs for mood and anxiety disorders have reached the market for over a decade. Why is there so little innovation in a sector that accounts for the largest proportion by far of sales of psychiatric drugs?

Medical subject headings